Skip to main content
Clinical Trials/NCT02067351
NCT02067351
Completed
Phase 2

Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy

Mayo Clinic1 site in 1 country6 target enrollmentApril 2014
ConditionsBreast Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Mayo Clinic
Enrollment
6
Locations
1
Primary Endpoint
Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
January 2017
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Daniela L. Stan, M.D

Daniela Stan, MD

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)

Time Frame: While receiving chemotherapy (usually 4-5 months)

Secondary Outcomes

  • Stress - measured by the Perceived Stress Scale - statistically and clinically significant reductions in stress(7-8 months)

Study Sites (1)

Loading locations...

Similar Trials